Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by Pj1958 on Nov 02, 2015 5:07pm

O'Leary

Said VRX is poisoned.. A lot better beaten up
health sector stocks are out there.He didn't mention
CXR, but it is a prime example example of a health care stock
thats been beaten up for no reason.
Comment by liambert on Nov 02, 2015 7:22pm
When the hype is dead, so is the hope.   Prior to the decline, both CXR and VRX prices represented the potential, now they represent the value of the corporation. Both will recover but at their own paces.  Change may be needed at both to restore investor confindence. 
Comment by TechTarget on Nov 02, 2015 11:34pm
And this misguided opinion of yours is based on what?  Many of us feel a quick recovery to 60 just based on the oversold condition.  At 60, it's running at 50% of its 52 high and a fraction of its calculated value.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities